Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Nature Methods|May 25, 2026
An encyclopedic regulatory and functional atlas of RNA interactomesKeren Zhou, Junhong Huang, Shurong Liu, et al.Molecular Cell|February 5, 2020
LARP7-Mediated U6 snRNA Modification Ensures Splicing Fidelity and Spermatogenesis in MiceXin Wang, Zhi-Tong Li, Yue Yan, et al.Cancer Discovery|July 19, 2022
Geospatial Immune Heterogeneity Reflects the Diverse Tumor-Immune Interactions in Intrahepatic CholangiocarcinomaYoupei Lin, Lihua Peng, Liangqing Dong, et al.Cell Genomics|November 14, 2025
Predominant mutated non-canonical tumor-specific antigens identified by proteogenomics demonstrate immunogenicity and tumor suppression in CRCHaitao Xiang, Xiangyu Guan, Yaohua Wei, et al.Elife|August 14, 2019
Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in miceShun Kishimoto, Jeffrey R Brender, Daniel R Crooks, et al.Oncogene|April 29, 2026
Crosstalk between integrin signaling and NAD⁺ biosynthetic pathways promotes glycolysis, proliferation, survival, and tumor growth in triple-negative breast cancerOrion Spellecy, Javeria Qadir, Rongbo Han, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 28, 2020
Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epitheliumYu Zhong, Kabhilan Mohan, Jinpeng Liu, et al.Nature Metabolism|July 23, 2020
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restrictionTingting Wang, J N Rashida Gnanaprakasam, Xuyong Chen, et al.Cell Reports. Medicine|March 31, 2026
Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinomaYoupei Lin, Lihua Peng, Haichao Zhao, et al.Cancer Cell|December 15, 2023
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinomaYunfan Sun, Pin Wu, Zefan Zhang, et al.Pageof 5